StreetAccount Summary: Stocks reaching new 52-week highs/lows (187 total)
StreetAccount Summary - Trading higher/lower: EU mid-morning
FDA panel to meet 9-Oct to discuss topics including influenza strains and allergen standardization
DBV Technologies has entered into a $150M sales agreement - 424B5 (€1.51, 0.00)
DBV Technologies reports Q2 GAAP EPS ($0.31) vs year-ago ($0.34) - 10-Q (€1.78, 0.00)
Powered by FactSet Research Systems Inc.